Skip to main content
. Author manuscript; available in PMC: 2020 Aug 15.
Published in final edited form as: Am J Cardiol. 2019 May 29;124(4):636–643. doi: 10.1016/j.amjcard.2019.05.014

Table 5.

Odds Ratios (95% Cl) of incident hs-cTnT≥14 ng/L and NT-proBNP≥100 pg/mL at MESA Exam 3 according to estimated sodium intake quintile.

Q1 (0.2-1.3
g/d)
Q2 (1.3-1.8
g/d)
Q3 (1.8-2.4
g/d)
Q4 (2.4-3.2
g/d)
Q5 (3.2-9.9
g/d)
hs-cTnT≥14 ng/L 43 (7%) 44 (7%) 40 (6.8%) 56 (8.9%) 54 (8.9%)
N 611 630 593 631 607
Model 1 1.11 (0.71, 1.73) Ref=1 0.96 (0.61, 1.52) 1.20 (0.79, 1.84) 1.31 (0.85, 2.02)
Model 2 1.14 (0.72, 1.80) Ref=1 0.98 (0.61, 1.55) 1.17 (0.76, 1.80) 1.25 (0.81, 1.95)
Model 3 1.15 (0.73, 1.81) Ref=1 0.98 (0.62, 1.57) 1.16 (0.75, 1.80) 1.24 (0.79, 1.93)
NT -proBNP≥100 pg/mL 103 (18.3%) 112 (19.7%) 119 (19.8%) 112 (17.9%) 105 (15.6%)
N 563 569 601 627 675
Model 1 0.86 (0.63, 1.17) Ref=1 1.20 (0.89, 1.63) 1.01 (0.75, 1.38) 1.02 (0.75, 1.39)
Model 2 0.89 (0.65, 1.23) Ref=1 1.23 (0.90, 1.67) 1.05 (0.77, 1.44) 1.10 (0.80, 1.51)
Model 3 0.90 (0.65, 1.23) Ref=1 1.22 (0.89, 1.66) 1.04 (0.76, 1.42) 1.10 (0.80, 1.52)

Model 1: age and sex.

Model 2: Model 1 plus race/ ethnicity, body mass index, smoking status, alcohol consumption, total cholesterol, high-density lipoprotein cholesterol, triglycerides, estimated glomerular filtration rate, lipid-lowering medication use, blood pressure–lowering medication, and history of diagnosed diabetes.

Model 3: Model 2 plus systolic BP